Floy

Floy develops AI-driven software that enables radiologists to generate additional revenue through opportunistic screening for critical health factors. Founded in 2021, Floy has raised €8.8 million and partnered with over 200 radiology centers. Providing opportunistic screening for regular care in radiology, Floy partners with radiologists to deliver advanced diagnostics that offer valuable insights, drive additional revenue and uphold high standards of care.

The product suite includes FloyBrain, FloySpine, and FloyMammo. FloySpine aids in early detection of osteoporosis, FloyMammo provides women undergoing mammography with cardiovascular risk insights, and FloyBrain enhances early detection of neurodegenerative diseases, improving diagnostic accuracy and patient outcomes.